The term sarcopenia, derived from the Greek words sarx for flesh and penia for loss, was first
introduced by Rosenberg 1 in 1989 to describe the loss of muscle mass that accompanies …

Sarcopenia has been established as a predictor of poor outcomes in various clinical
settings. It is particularly prevalent in heart failure, a clinical syndrome that poses significant …

The prolonged immobilization associated with COVID-19 infection and the restrictions
imposed by the pandemic have determined major changes in physical activity and eating …

Background This study aimed to adjust and cross‐validate skeletal muscle mass
measurements between bioimpedance analysis (BIA) and dual‐energy X‐ray …

Abstract The South Asian population is rapidly ageing and sarcopenia is likely to become a
huge burden in this region if proper action is not taken in time. Several sarcopenia …

Body composition assessment (ie, the measurement of muscle and adiposity) impacts
several cancer-related outcomes including treatment-related toxicities, treatment responses …

Rationale Cancer is associated with muscle wasting. However, optimal protein intake has
not been determined, limiting the efficacy of nutritional interventions. This systematic review …

Background Sarcopenia, a loss of skeletal muscle mass or function, affects up to 50% of
patients with inflammatory bowel disease (IBD) and is associated with poor clinical …

Background Sarcopenia is associated with adverse outcomes among older adults with
cancer; however, no easily applied sarcopenia measure exists for use in clinical practice …

Sarcopenia is defined as a progressive loss of skeletal muscle mass, strength, and function.
1 Sarcopenia is often associated with ageing and frailty and, more recently, has been linked …